The document was adopted to ensure further developing pharmaceutical industry of Uzbekistan, saturating internal market with quality and effective local medicaments, expanding production of import-replacing medicaments.
The resolution corrected a list of medicaments, at import of which the preferences on value added tax, envisaged by point 6 of article 211 of Tax Code of Uzbekistan, will not be imposed.
The preference exempted from value added tax at import of medicaments and medical (veterinary) products, as well as raw materials, imported in line with approved by the legislation, to produce medicaments.
The resolution increased number of medicaments, included to list, rose from 45 to 67.
The same resolution revoked right of the Ministry of Healthcare to introduce new names of medicaments to the list.